Bangladesh vs Greece: The number of people with susceptibility test result for rifampicin
Bangladesh
43.54
in 2021
Greece
45.08
in 2021
Bangladesh rank
121st
Greece rank
119th
The number of people with susceptibility test result for rifampicin over time
- Bangladesh
- Greece
How they compare
Greece currently reports 45.08 against 43.54 in Bangladesh, a difference of 1.54.
Across all 5 years both countries report, Greece has been ahead every year.
Bangladesh ranks 121st and Greece ranks 119th of 146 countries.
Greece has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bangladesh | Greece | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 26.1 | 55.64 | 29.54 | Greece |
| 2020s | 39.25 | 69.01 | 29.75 | Greece |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Bangladesh or Greece?
- Greece, at 45.08 against 43.54 in Bangladesh as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Bangladesh and Greece?
- 1.54, with Greece ahead.
- How many years of comparable data are there for Bangladesh and Greece?
- 5 years are reported by both, from 2017 to 2021.
- How do Bangladesh and Greece rank globally for the number of people with susceptibility test result for rifampicin?
- Bangladesh ranks 121st and Greece ranks 119th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.